Aankondiging • Apr 16
Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026 Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China Aankondiging • Mar 31
Huafon Chemical Co.,Ltd to Report Q1, 2026 Results on Apr 22, 2026 Huafon Chemical Co.,Ltd announced that they will report Q1, 2026 results on Apr 22, 2026 Aankondiging • Dec 31
Huafon Chemical Co.,Ltd to Report Fiscal Year 2025 Results on Mar 28, 2026 Huafon Chemical Co.,Ltd announced that they will report fiscal year 2025 results on Mar 28, 2026 Aankondiging • Sep 30
Huafon Chemical Co.,Ltd to Report Q3, 2025 Results on Oct 25, 2025 Huafon Chemical Co.,Ltd announced that they will report Q3, 2025 results on Oct 25, 2025 Aankondiging • Sep 04
Huafon Chemical Co.,Ltd Proposes Interim Cash Dividend for the Year 2025 Huafon Chemical Co.,Ltd proposed interim cash dividend of CNY 0.50000000 per 10 shares for the year 2025. Aankondiging • Jul 02
Huafon Chemical Co.,Ltd to Report First Half, 2025 Results on Aug 12, 2025 Huafon Chemical Co.,Ltd announced that they will report first half, 2025 results on Aug 12, 2025 Aankondiging • Apr 01
Huafon Chemical Co.,Ltd Proposes Final Cash Dividend for the Year 2024 Huafon Chemical Co.,Ltd announced that on 31 March 2025 the profit distribution proposal for 2024: Cash dividend (tax included) of CNY 1.50000000 per 10 shares. Aankondiging • Mar 31
Huafon Chemical Co.,Ltd to Report Q1, 2025 Results on Apr 26, 2025 Huafon Chemical Co.,Ltd announced that they will report Q1, 2025 results on Apr 26, 2025 Aankondiging • Mar 29
Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025 Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China Aankondiging • Dec 31
Huafon Chemical Co.,Ltd to Report Fiscal Year 2024 Results on Mar 29, 2025 Huafon Chemical Co.,Ltd announced that they will report fiscal year 2024 results on Mar 29, 2025 Aankondiging • Oct 31
Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd. Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd. on October 28, 2024. The consideration consist of cash and common equity. Aankondiging • Oct 30
Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua. Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua on October 28, 2024. Huafon Chemical intends to acquire 100% of the equity of Zhejiang Huafon Synthetic Resin through issuing shares and paying cash. After the agreement is signed, both parties will continue to actively communicate, verify, and negotiate specific details of the transaction plan, transaction method, transaction price, share issuance price, share issuance quantity, and other matters, and will subsequently sign all formal agreements related to this transaction. Reported Earnings • Oct 28
Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.12 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.12 in 3Q 2023). Revenue: CN¥6.63b (down 6.1% from 3Q 2023). Net income: CN¥496.5m (down 13% from 3Q 2023). Profit margin: 7.5% (down from 8.1% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Aankondiging • Sep 30
Huafon Chemical Co.,Ltd to Report Q3, 2024 Results on Oct 26, 2024 Huafon Chemical Co.,Ltd announced that they will report Q3, 2024 results on Oct 26, 2024 Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥7.78, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥3.79 per share. Reported Earnings • Aug 10
Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥7.09b (up 10% from 2Q 2023). Net income: CN¥834.7m (up 15% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Aankondiging • Jun 29
Huafon Chemical Co.,Ltd to Report First Half, 2024 Results on Aug 10, 2024 Huafon Chemical Co.,Ltd announced that they will report first half, 2024 results on Aug 10, 2024 Aankondiging • May 28
Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024 Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024, at 14:30 China Standard Time. Location: 2F, No. 1688, Development Zone Avenue, Economic Development Zone, Rui'an, Zhejiang China Reported Earnings • Apr 20
First quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.13 in 1Q 2023). Revenue: CN¥6.66b (up 7.5% from 1Q 2023). Net income: CN¥683.4m (up 8.2% from 1Q 2023). Profit margin: 10% (in line with 1Q 2023). Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Aankondiging • Mar 30
Huafon Chemical Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024 Huafon Chemical Co., Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024 Valuation Update With 7 Day Price Move • Feb 08
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥6.99, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.68 per share. Aankondiging • Dec 30
Huafon Chemical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024 Huafon Chemical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 20, 2024 Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.004 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.12 (up from CN¥0.004 in 3Q 2022). Revenue: CN¥7.06b (up 16% from 3Q 2022). Net income: CN¥569.9m (up CN¥548.7m from 3Q 2022). Profit margin: 8.1% (up from 0.3% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 11
Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.21 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.21 in 2Q 2022). Revenue: CN¥6.43b (down 1.7% from 2Q 2022). Net income: CN¥727.2m (down 30% from 2Q 2022). Profit margin: 11% (down from 16% in 2Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat. Aankondiging • Jul 01
Huafon Chemical Co., Ltd. to Report First Half, 2023 Results on Aug 11, 2023 Huafon Chemical Co., Ltd. announced that they will report first half, 2023 results on Aug 11, 2023 Aankondiging • Jun 09
Huafon Chemical Co., Ltd. Approves the Cash Dividend for the Year 2022 Huafon Chemical Co., Ltd. approved the Cash dividend (tax included) of CNY 1.50000000 per 10 shares for the year 2022, at the AGM held on June 7, 2023. Aankondiging • May 19
Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023 Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2023 estimated continuing connected transactions; to consider confirmation of 2022 remuneration for directors, supervisors and senior management; and to consider other mattters. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.29 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.29 in 1Q 2022). Revenue: CN¥6.19b (down 15% from 1Q 2022). Net income: CN¥631.4m (down 54% from 1Q 2022). Profit margin: 10% (down from 19% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Dec 08
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 7.0%. The fair value is estimated to be CN¥9.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 47%. Revenue is forecast to grow by 19% in 2 years. Earnings is forecast to grow by 23% in the next 2 years. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.004 (vs CN¥0.49 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.004 (down from CN¥0.49 in 3Q 2021). Revenue: CN¥6.10b (down 25% from 3Q 2021). Net income: CN¥21.2m (down 99% from 3Q 2021). Profit margin: 0.3% (down from 28% in 3Q 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 05
Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.48 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.48 in 2Q 2021). Revenue: CN¥6.54b (down 7.8% from 2Q 2021). Net income: CN¥1.03b (down 53% from 2Q 2021). Profit margin: 16% (down from 31% in 2Q 2021). The decrease in margin was primarily driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Jun 08
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 7.5%. The fair value is estimated to be CN¥10.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 58%. Revenue is forecast to grow by 6.4% in 2 years. Earnings is forecast to grow by 0.5% in the next 2 years. Reported Earnings • May 02
First quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.35 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.29 (down from CN¥0.35 in 1Q 2021). Revenue: CN¥7.29b (up 26% from 1Q 2021). Net income: CN¥1.36b (down 17% from 1Q 2021). Profit margin: 19% (down from 28% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 25
Third quarter 2021 earnings released: EPS CN¥0.49 (vs CN¥0.12 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥8.12b (up 111% from 3Q 2020). Net income: CN¥2.28b (up 295% from 3Q 2020). Profit margin: 28% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year and the company’s share price has also increased by 46% per year. Reported Earnings • Aug 29
Second quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.085 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.10b (up 104% from 2Q 2020). Net income: CN¥2.21b (up 463% from 2Q 2020). Profit margin: 31% (up from 11% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Apr 13
Full year 2020 earnings released: EPS CN¥0.49 (vs CN¥0.43 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥14.7b (up 6.4% from FY 2019). Net income: CN¥2.28b (up 24% from FY 2019). Profit margin: 16% (up from 13% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥11.06, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 134% over the past three years. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥13.66, the stock is trading at a trailing P/E ratio of 35.3x, down from the previous P/E ratio of 42.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 170%. Is New 90 Day High Low • Feb 20
New 90-day high: CN¥16.20 The company is up 56% from its price of CN¥10.41 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.24 per share. Is New 90 Day High Low • Jan 21
New 90-day high: CN¥13.52 The company is up 81% from its price of CN¥7.47 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.05 per share. Valuation Update With 7 Day Price Move • Jan 07
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥12.26, the stock is trading at a trailing P/E ratio of 31.7x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 148%. Is New 90 Day High Low • Jan 06
New 90-day high: CN¥11.51 The company is up 56% from its price of CN¥7.40 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.07 per share. Valuation Update With 7 Day Price Move • Nov 13
Market bids up stock over the past week After last week's 18% share price gain to CN¥9.85, the stock is trading at a trailing P/E ratio of 25.5x, up from the previous P/E ratio of 21.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 111%. Is New 90 Day High Low • Nov 09
New 90-day high: CN¥8.99 The company is up 25% from its price of CN¥7.20 on 11 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.57 per share. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥2.11b, down 17% from the prior year. Total revenue was CN¥15.8b over the last 12 months, down 19% from the prior year. 
